Prasterone vaginal - Kanebo

Drug Profile

Prasterone vaginal - Kanebo

Alternative Names: KB-60; Mylis

Latest Information Update: 26 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nippon Organon
  • Developer Innothera; MSD KK
  • Class Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action DNA-directed RNA polymerase stimulants; Protein synthesis stimulants; Testosterone congener stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Labour induction

Most Recent Events

  • 16 Nov 1999 Kanebo's pharmaceutical business has been merged with Organon's Japanese operations to form Nippon Organon
  • 29 May 1998 Suspended-phase II for Labour induction in Germany (Vaginal)
  • 29 May 1998 Suspended-phase II for Labour induction in Spain (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top